Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) shares fell 8.3% during trading on Thursday . The stock traded as low as $61.33 and last traded at $62.42. 207,041 shares traded hands during trading, a decline of 82% from the average session volume of 1,172,858 shares. The stock had previously closed at $68.08.
Analysts Set New Price Targets
Several equities research analysts have recently commented on the company. JPMorgan Chase & Co. boosted their price target on Tempus AI from $42.00 to $47.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 7th. Loop Capital upped their price objective on Tempus AI from $48.00 to $57.00 and gave the company a “buy” rating in a research report on Tuesday, October 15th. Piper Sandler reissued a “neutral” rating and issued a $70.00 target price (up previously from $40.00) on shares of Tempus AI in a research note on Tuesday. Stifel Nicolaus lowered shares of Tempus AI from a “buy” rating to a “hold” rating and raised their target price for the stock from $45.00 to $65.00 in a research report on Monday. Finally, Bank of America lowered Tempus AI from a “buy” rating to a “neutral” rating and raised their price target for the stock from $45.00 to $60.00 in a research note on Wednesday, October 2nd. Three equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $54.22.
View Our Latest Analysis on TEM
Tempus AI Stock Down 13.4 %
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently bought and sold shares of the company. EFG Asset Management North America Corp. acquired a new position in Tempus AI during the second quarter valued at $1,333,000. ARK Investment Management LLC acquired a new stake in Tempus AI in the 2nd quarter valued at $18,294,000. Northwestern University acquired a new position in Tempus AI during the second quarter worth $491,000. Alphabet Inc. acquired a new position in Tempus AI in the second quarter valued at about $54,289,000. Finally, Pier Capital LLC bought a new stake in Tempus AI during the second quarter worth about $2,301,000.
About Tempus AI
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Recommended Stories
- Five stocks we like better than Tempus AI
- What Are Dividend Achievers? An Introduction
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- How to Calculate Return on Investment (ROI)
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- What Are Dividend Contenders? Investing in Dividend Contenders
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.